等待开盘 08-28 09:30:00 美东时间
+0.040
+0.30%
今日重点评级关注:摩根士丹利:维持Ultragenyx Pharmaceutical"超配"评级,目标价从67美元升至74美元;Truist Securities:维持Solid Biosciences"买入"评级,目标价从16美元升至20美元
08-24 16:40
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Quinn Fredrickson downgraded Teradyne Inc (NASDAQ:TER) from Outperform to Neutral a...
08-21 23:08
JP Morgan analyst Samik Chatterjee downgrades DoubleVerify Holdings (NYSE:DV) from Overweight to Neutral and announces $13.6 price target.
08-21 21:05
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
08-18 08:19
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
08-11 04:19
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24
华盛资讯8月7日讯,DoubleVerify公布2026财年Q2业绩,公司Q2营收1.94亿美元,同比增长2.5%,归母净利润0.13亿美元,同比增长47.5%。
08-07 20:35
Raymond James analyst Andrew Marok downgrades DoubleVerify Holdings (NYSE:DV) from Outperform to Market Perform.
08-07 19:57
尼尔森控股已同意以21.5亿美元收购DoubleVerify控股公司,意在强化自身评级业务。 这家评级服务商发布声明称,DoubleVerify投资者将...
08-07 07:20
华盛资讯8月7日讯,DoubleVerify公布2026财年Q2业绩,公司Q2营收1.94亿美元,同比增长2.5%,归母净利润0.13亿美元,同比增长47.5%。
08-07 05:37